Induction of Apoptosis and Inhibition of Growth of Human Hepatoma HepG2 Cells by Heparin

Hepato-Gastroenterology

Volumn 50, Issue 54, 2003, Pages 1864-1866

  Karti, S Sami ^a,b,f   Ovali, Ercument ^a,b   Ozgur, Orhan ^a,c   Yilmaz, Mustafa ^a,b   Sommez, Mehmet ^a,b   Ratip, Siret ^a,e   Ozdemir, Feyyaz ^a,d  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b Divisions of Hematology   (Turkey)

^c Divisions of Gastroenterology   (Turkey)

^d Divisions of Medical Oncology   (Turkey)

^e MARMARA UNIVERSITY   (Turkey)

^f Hematoloji Bolumu Karadeniz T   (Turkey)

Author keywords

Apoptosis; Heparin; Hepatoma; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; HEPARIN; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; MITOSIS INHIBITION; PRIORITY JOURNAL;

ANTICOAGULANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL COUNT; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN; HUMANS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0344961435     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mandal AK, Lyden TW, Saklayen MG: Heparin lowers blood pressure: biological and clinical perspectives. Kidney Int 1995; 47:1017-1022.
2. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP: Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation. Blood 1993; 82: 3253-3258.
3. Guyton JR, Rosenberg RD, Clowes AW, Karnoysky MJ: Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with coagulant and nonanticoagulant heparin. Circ Res 1980; 46:625-634.
4. Clowes AW, Clowes MM: Kinetics of cellular proliferation after arterial injury: II. Inhibition of smooth muscle growth by heparin. Lab Invest 1985; 52:611-616.
5. Manaster J, Chezar J, Shurtz-Swirski R, Shapiro G, Tendler Y, Kristal B, Shasha SM, Sela S: Heparin induces apoptosis in human peripheral blood neutrophils. B J Haematol 1996; 94:48-52.
6. Erduran E, Tekelioglu Y, Gedik Y, Yildiran A: Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study. Am J Hematol 1999; 61:90-93.
7. Li HL, Ye KH, Zhang HW, Luo YR, Ren XD, Xiong AH, Situ R: Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells. Cell Res 2001; 11:311-315.
8. Li HL, Ren XD, Zhang HW, Ye CL, Lv JH, Zheng PE: Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells. Acta Pharmacol Sin 2002; 23:167-172.
9. Fedarko NS, Ishihara M, Conrad HE: Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan. J Cell Physiol 1989; 139:287-294.
10. Hotz MA, Gong J, Traganos F, Darzynkiewicz: Flow cytometric detection of apoptosis: comparison of in situ DNA degradation and chromatin changes. Cytometry 1994; 15:237-244.
11. Bolton WE, Mikulka WR, Healy CG, Schmittling RJ, Kenyon NS: Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells. Cytometry 1992; 13:117-126.
12. Reilly CF, Fritze LM, Rosenberg RD: Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J Cell Physiol 1986; 129:11-19.
13. Castellot JJ Jr, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ: Binding and internalization of heparin by vascular smooth muscle cell. J Cell Physiol 1985; 124:13-20.
14. Wright TC Jr, Pukac LA, Castellot JJ Jr, Karnovsky MJ, Levine RA, Kun-Park HY, Campisi J: Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase dependent pathway. Proc Natl Acad Sci USA 1989; 86:3199-3203.
15. Pukac LA, Hirsch GM, Lormeau JC, Petitou M, Choay J, Karnovsky MJ: Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am J Pathol 1991; 136:1501-1509.